arrow
H

Hans Wildiers

University Hospital of Leuven
H指数:84
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of STYXL1 as novel susceptibility gene for anthracycline-induced cardiotoxicity in breast cancer patients

鉴定STYXL1作为乳腺癌患者蒽环类药物诱导的心脏毒性的新型易感基因

2026-10-270
PRE
De-Escalated Chemotherapy and Endocrine Therapy Outcomes in Young Women with Stage I HR+/HER2+ Breast Cancer: An International Real-World Study.

在年轻女性中,针对I期HR+/HER2+乳腺癌的降级化疗和内分泌治疗效果:一项国际真实世界研究。

2026-06-110
OAAI
De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+breast cancer: An international real-world study.

年轻女性中I期HR+/HER2+乳腺癌降级化疗和内分泌治疗效果:一项国际真实世界研究

2026-06-010
PRE
The ESMO/SIOG Cancer in the Elderly Working Group pragmatic strategies for clinical trial designs and endpoints in older adults with cancer

ESMO/SIOG老年肿瘤工作组关于老年癌症患者临床试验设计与终点的实用策略

2026-02-230
OAAI
Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue

抗体偶联药物靶点在乳腺癌转移灶和正常组织死后样本中的表达

2025-12-260
OAAI
Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapy.

辅助性卵巢功能抑制和芳香化酶抑制剂在激素受体和HER2阳性乳腺癌绝经前患者中的应用,按化疗和曲妥珠单抗的时机及新辅助治疗的反应。

2025-12-060
OAAI
ctDNA detectability and representativeness in seven body liquids from patients with metastatic breast cancer

ctDNA在转移性乳腺癌患者七种体液中的检测性与代表性

2025-12-020
OAAI
ASSOCIATION BETWEEN TYPE AND LOCATION OF GERMLINE BRCA1/2 PATHOGENIC OR LIKELY PATHOGENIC VARIANTS WITH PHENOTYPE AND PROGNOSIS IN YOUNG PATIENTS WITH BREAST CANCER: RESULTS FROM AN INTERNATIONAL COHORT STUDY

年轻乳腺癌患者BRCA1/2致病性或可能致病性变异的类型和位置与表型和预后之间的关系: 一项国际队列研究的结果

2025-11-170
OAAI
Enhancing translational research in metastatic cancer through an open science environment: the UPTIDER experience

通过开放科学环境增强转移性癌症的转化研究:UPTIDER项目经验

2025-11-060
OAAI
The role of body mass index at diagnosis in patients with inflammatory breast cancer

炎性乳腺癌患者诊断时体重指数的作用

2025-10-120
OAAI
Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers

年轻BRCA携带者在孕期被诊断患有乳腺癌后,再次怀孕的安全性

2025-08-130
OAAI
Effectiveness of comprehensive geriatric assessment with extensive patient coaching for improving quality of life in older patients with solid tumours receiving systemic therapy (G-oncoCOACH): a multicentre randomised controlled trial

综合老年评估结合广泛的患者指导对接受系统性治疗的有实体瘤的老年患者生活质量改善的效果(G-oncoCOACH):一项多中心随机对照试验

2025-08-130
OAAI
Corrigendum to “Histopathological Insights into Metastatic Breast Cancer Gained From Rapid Autopsies” [Laboratory Investigation 105(2025) 104202]

勘误:“通过快速尸检获取的转移性乳腺癌的病理解剖学见解”[Laboratory Investigation 105(2025) 104202]

2025-08-040
OAAI
Histopathological Insights into Metastatic Breast Cancer Gained From Rapid Autopsies

通过快速尸检获得的转移性乳腺癌的病理学见解

2025-05-290
OAAI
Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (sept,10.1038/s41591-024-03261-7,2024)
2024-12-090
OAAI